IMDX
Insight Molecular Diagnostics
IMDX
IMDX
34 hedge funds and large institutions have $5.64M invested in Insight Molecular Diagnostics in 2016 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 10 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
30% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 10
67% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 12
Holders
34
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$356K | |
| 2 | +$74K | |
| 3 | +$42K | |
| 4 |
MHP
Manatuck Hill Partners
Westport,
Connecticut
|
+$23.8K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$4.23K |
Top Sellers
| 1 | -$238K | |
| 2 | -$163K | |
| 3 | -$135K | |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$84.3K |
| 5 |
New York State Common Retirement Fund
Albany,
New York
|
-$63K |